Dioxaphetyl Butyrate
From Wikipedia, the free encyclopedia
|
Dioxaphetyl Butyrate
|
|
| Systematic (IUPAC) name | |
| ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C22H27NO3 |
| Mol. mass | 353.45 g/mol |
| SMILES | & |
| Synonyms | Dioxaphetyl Butyrate, Amidalgon, Spasmoxal |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Dioxaphetyl Butyrate (Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other drugs such as dextropropoxyphene.
It produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

